Agilex is pleased to introduce Mallory Jolly as our new Senior Business Development Director to the...
Agilex Demystifies the Rapidly Evolving Landscape of Drug Development Post-Covid, the field of bi...
애질렉스 바이오랩스가 힐리어스 네트워크의 일원으로서 글로벌 확장과 기업 발전을 지속하는 가운데, 스티븐 맥킨타이어가 최고경영자(CEO)로 선임되었습니다.
ddPCR technology provides an opportunity to streamline research and development processes, saving ti...
Small and large molecule drug development often necessitates distinct analytical methodologies. Agil...
Agilex has extensive experience developing and validating like-binding assays for specific immune-on...
Come to Our EBF Session in Barcelona to Hear how Agilex Can Make Your PK Data SPARCL SPARCL stand...
애질렉스 바이오랩스가 힐리어스 네트워크의 일원으로서 글로벌 확장과 기업 발전을 지속하는 가운데, 스티븐 맥킨타이어가 최고경영자(CEO)로 선임되었습니다.
by Holly Stefl, Chief Commercial Officer It is with much enthusiasm that Agilex Biolabs introduce...
by Kurt Sales In the realm of bioanalytical research, immunoassays stand as a cornerstone technol...
by Holly Stefl, Chief Commercial Officer Agilex Biolabs is proud to introduce the West Coast of t...
by Dr. Kurt Sales, Chief Scientific Officer Pharmacokinetics is a key component in a drug develop...
"*" indicates required fields
